期刊文献+

小儿肺热咳喘口服液结合阿奇霉素治疗小儿肺炎支原体肺炎疗效观察 被引量:15

Observation on the curative effect of azithromycin in treatment of mycoplasma pneumonia in children with infantile Feirekechuan oral liquid
下载PDF
导出
摘要 目的:小儿肺热咳喘口服液结合阿奇霉素治疗小儿肺炎支原体肺炎疗效观察,增加小儿肺炎支原体肺炎的治疗效果。方法:根据随机性原则选取小儿肺炎支原体肺炎患者66例,将66例确诊为小儿肺炎支原体肺炎患者作为临床研究对象,随机盲法分为两组,对照组33例,观察组33例,对照组采取常规治疗肺炎支原体肺炎加上阿奇霉素进行治疗,观察在组采取在常规肺炎治疗方法的基础上增加小儿肺热咳喘口服液结合阿奇霉素治疗,治疗后观察两组患者治疗疗效,对比分析总结优异的治疗方法。结果:表1结果显示,对照治愈患儿13例(39.39%)远远少于观察组19例(57.56%),无效的患儿中对照组高达9例(27.27%),观察组仅2例(6.06%);两组患者比较差异有统计学意义(P<0.05)。结论:小儿肺炎支原体肺炎患者采取常规治疗以及小儿肺热咳喘口服液结合阿奇霉素进行治疗,疗效显著,且无明显不良反应,临床治疗可广泛应用。 Objective To observe the curative effect of azithromycin in treatment of mycoplasma pneumonia in children with infantile Feirekechuan oral liquid,increase the therapeutic effect of Mycoplasma pneumoniae pneumonia in children. Method According to the principle of random,66 patients of children with Mycoplasma pneumoniae pneumonia were selected,66 cases were diagnosed as Mycoplasma pneumonia patients as clinical research object,they were randomly divided into two groups,33 cases in the control group,33 cases in the observation group,the control group received routine treatment mycoplasma pneumonia with azithromycin treatment,observation group to increase in infantile Feirekechuan oral liquid combined with azithromycin treatment based on routine treatment of pneumonia,after treatment in two groups were observed the treatment effect,comparative analysis to summarize the treatment method of the excellent. Results Table 1 showed that the control group 13 cases were cured(39. 39%),which was far less than the observation group of 19 cases(57. 56%),invalid children in control group of 9cases(27. 27%),the observation group only 2 cases(6. 06%);the two groups were significantly different,with statistical significance( P〈0. 05). Conclusion The patients with mycoplasma pneumonia in children treated with conventional and infantile Feirekechuan oral liquid combined with azithromycin treatment,the curative effect is remarkable,and no obvious adverse reactions,can be widely used in clinical treatment.
出处 《吉林医学》 CAS 2017年第3期441-442,共2页 Jilin Medical Journal
关键词 小儿肺炎支原体肺炎 小儿肺热咳喘口服液 阿奇霉素 疗效观察 Mycoplasma pneumonia Infantile Feirekechuan oral liquid Azithromycin Clinical observation
  • 相关文献

参考文献4

二级参考文献50

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:604
  • 2聂青和.肝肾综合征诊断及治疗进展[J].实用临床医药杂志,2007,11(3):10-12. 被引量:7
  • 3Waites KB,Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen[J].Clin Mierobiol Rev,2004,17(4):697-728.
  • 4Chaudhry R,Varahney AK,Malhotra P.Adhesion proteins of Mycoplas ma pneumoniae[J].Front Biosci,2007,12:690-699.
  • 5Yavlovich A,Tarshis M,Rottem S.Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells[J].FEMS Microbiol Lett,2004,233(2):241-246.
  • 6Kannan TR,Provenzano D,Wright JR,et al.Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae[J].Infect Immun,2005,73 (5):2828-2834.
  • 7Kannan TR,Baseman JR.ADP-ribosylating and vacuolating eytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens[J].Proc Nail Acad Sci USA,2006,103 (17):6724-6729.
  • 8Kunnan TR,Provenzano D,Wright JR,et al.Identification and characterization of human surfactant protein A binging protein of Mycoplasma pneumoniae[J].Infect Immun,2005,73(5):2828-2834.
  • 9Shimizu T,Kida Y,Kuwano K.A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1,TLR2 and TLR6[J].J Immunol,2005,175(7):4641-4646.
  • 10Into T,Kiura K,Yasuda M.et al.Stimulation of human Tolllike receptor (TLR)2 and TLR6 with membrane lipoproteins of Mycoplasma fementans induces apoptotic cell death after NFkappa B activation[J].Cell Microbiol,2004.6(2):187-199.

共引文献248

同被引文献185

引证文献15

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部